Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 14, 2024
Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With SotorasibSophie M Ernst, Ronald van Marion, Peggy N Atmodimedjo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 29, 2024
Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastasesPascale C S Rietveld, Niels A D Guchelaar, Ruben A G van Eerden, et al.
International Journal of Cancer|March 16, 2024
Darolutamide does not interfere with OATP-mediated uptake of docetaxelStefan A J Buck, Zahra Talebi, Thomas Drabison, et al.
Clinical Pharmacology and Therapeutics|December 21, 2018
Influence of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib: A Randomized Crossover Pharmacokinetic StudyFemke M de Man, Koen G A M Hussaarts, Mirjam de With, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for GlioblastomaIoannis Ntafoulis, Stijn L W Koolen, Olaf van Tellingen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2013
CYP3A4*22 genotype and systemic exposure affect paclitaxel-induced neurotoxicityAnne-Joy M de Graan, Laure Elens, Jason A Sprowl, et al.
Frontiers in Pharmacology|December 3, 2021
Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal CancerRuben A G van Eerden, Leni van Doorn, Femke M de Man, et al.
Therapeutic Advances in Medical Oncology|March 24, 2022
Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatmentStefan A J Buck, C Louwrens Braal, Maaike M Hofman, et al.
Pharmaceutics|August 23, 2020
Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of SorafenibKoen G A M Hussaarts, Leni van Doorn, Karel Eechoute, et al.
The Oncologist|September 5, 2006
Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled studyFloris A de Jong, Diederik F S Kehrer, Ron H J Mathijssen, et al.
Pageof 9